Clinical Trial: Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia
Clinical Trial: Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic LeukemiaSponsor and Collaborators
Stanford University
Millennium Pharmaceuticals, Inc.
Contact
Contact: Richa Rajwanshi
(650) 736-4031
richar@stanford.edu
Principal Investigator
Bruno Carneiro de Medeiros Stanford University
ClinicalTrials.gov Identifier
NCT01162031
